HANSA BIOPHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.93 USD | -9.98% |
|
-.--% | +29.82% |
| Apr. 18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
| Apr. 18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Hansa Biopharma AB
Price target over the last 5 years
History of analyst recommendation changes
80ec51e9c7d7f7c513d7c388.Vyja5Y5LBOXBnK3_IwV5_LWNHD2pG7HlK_8j_m9reaA.IU3ql8ITcazw1f3ObTA4ivK-ZF7sbPe3HY8XyS1bNuctd4W3-2ZBkpLW7A~af49abfed50049a0c1760bd5b67ac699
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
29.74
SEK
Average target price
105
SEK
Spread / Average Target
+253.06%
High Price Target
175
SEK
Spread / Highest target
+488.43%
Low Price Target
57
SEK
Spread / Lowest Target
+91.66%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- HNSA Stock
- HNSBF Stock
- Consensus Hansa Biopharma AB
